Govt Invokes Key Clause to Maintain Stent Output
New Delhi: The government on Tuesday made it mandatory for stent makers to maintain production and supply of coronary stents by invoking an emergency clause under drug price control law citing reports of shortage in market. “After due deliberations on the current situation and alternatives available with the govt to resume normal supply of coronary stents, it was decided to invoke the powers of Section 3 (i) of DPCO, 2013,” said the department of pharmaceuticals in a letter to stent makers.
The department said there have been reports of shortage of coronary stents in markets/hospitals. Last week, the government had slashed prices of stents by up to 85% by capping them at ₹ 7,260 for bare metal ones and ₹ 29,600 for the drug eluting variety. Under Section 3 (i) of DPCO, 2013, the government can regulate distribution and direct any manufacturer to increase production and sell products.
Under the clause, the govt can regulate distribution and direct any manufacturer to increase production and sell products